Showing results (921-930 of 959) with videos related to

Sort By:
Pageof 96
Blood|April 15, 2024
Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trialMoritz Fürstenau, Adam Giza, Jonathan Weiss, et al.
Plos Biology|August 11, 2018
Transcriptional programming of lipid and amino acid metabolism by the skeletal muscle circadian clockKenneth Allen Dyar, Michaël Jean Hubert, Ashfaq Ali Mir, et al.
The Journal of Rheumatology|December 4, 2018
Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody StatusMelanie Hagen, Matthias Englbrecht, Judith Haschka, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
Demonstration of a Si3N4 Microring Resonator-Based Aptasensor for Human Urokinase-type Plasminogen Activator (uPA) Detection in Point-of-Care DiagnosticsJakob Reck, Klara Mihov, Tim-Henry Jakob, et al.
Trials|September 12, 2022
Effectiveness of a complex regional advance care planning intervention to improve care consistency with care preferences: study protocol for a multi-center, cluster-randomized controlled trial focusing on nursing home residents (BEVOR trial)Kornelia Götze, Claudia Bausewein, Berend Feddersen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 2015
Critical role of platelet glycoprotein ibα in arterial remodelingSue Chandraratne, Marie-Luise von Bruehl, Judith-Irina Pagel, et al.
Brain Topography|July 29, 2023
EEG-Meta-Microstates: Towards a More Objective Use of Resting-State EEG Microstate Findings Across StudiesThomas Koenig, Sarah Diezig, Sahana Nagabhushan Kalburgi, et al.
Nature Communications|November 22, 2018
Publisher Correction: Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetesChristoffer Clemmensen, Sigrid Jall, Maximilian Kleinert, et al.
Annals of the Rheumatic Diseases|October 21, 2015
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatmentJuergen Rech, Axel J Hueber, Stephanie Finzel, et al.
Nature Communications|October 25, 2018
Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetesChristoffer Clemmensen, Sigrid Jall, Maximilian Kleinert, et al.
Pageof 96